Literature DB >> 32398203

Modelling the potential impact of adherence technologies on tuberculosis in India.

N Arinaminpathy1, D P Chin2, K S Sachdeva3, R Rao3, K Rade4, S A Nair5, P Dewan6.   

Abstract

BACKGROUND: For patients taking standard first-line tuberculosis treatment, missing 10% or more of their doses increases the risk of relapse six-fold. Digital technologies offer new approaches to adherence support for TB patients. We estimated the potential impact of new adherence technologies in India.
METHOD: We developed a mathematical model of TB transmission dynamics in India, capturing the independent effects of missed doses and treatment default on post-treatment recurrence. We simulated the impact of interventions to address both missed doses and treatment default in the public and private healthcare sector.
RESULTS: Adherence interventions, if deployed optimally in the public sector alone, would reduce cumulative TB incidence by 7.3% (95% credible intervals [CrI] 4.7-11) between 2020 and 2030, and by 16% (95% CrI 11-23) if also deployed in the private sector. This impact is roughly proportional to the effectiveness of the interventions. Reducing missed doses reduced incidence by 12% (95% CrI 7.0-18), while reducing treatment default reduced incidence by 7.9% (95% CrI 3.2-13).
CONCLUSION: Minimising missed doses is at least as important as promoting treatment completion. Our results suggest that emerging technologies to improve treatment adherence could have a substantial impact on TB incidence and mortality in India.

Entities:  

Mesh:

Year:  2020        PMID: 32398203     DOI: 10.5588/ijtld.19.0472

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

Review 1.  All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era.

Authors:  Helen R Stagg; Mary Flook; Antal Martinecz; Karina Kielmann; Pia Abel Zur Wiesch; Aaron S Karat; Marc C I Lipman; Derek J Sloan; Elizabeth F Walker; Katherine L Fielding
Journal:  ERJ Open Res       Date:  2020-11-02

2.  Effect of using electronic medication monitors on tuberculosis treatment outcomes in China: a longitudinal ecological study.

Authors:  Ni Wang; Lei Guo; Hemant Deepak Shewade; Pruthu Thekkur; Hui Zhang; Yan-Li Yuan; Xiao-Meng Wang; Xiao-Lin Wang; Miao-Miao Sun; Fei Huang; Yan-Lin Zhao
Journal:  Infect Dis Poverty       Date:  2021-03-17       Impact factor: 4.520

3.  Formative acceptance of ingestible biosensors to measure adherence to TB medications.

Authors:  Clint Vaz; Nisha K Jose; Jeremiah Jacob Tom; Georgia R Goodman; Jasper S Lee; Rana Prathap Padappayil; Manjunath Madathil; Conall O'Cleirigh; Rashmi Rodrigues; Peter R Chai
Journal:  BMC Infect Dis       Date:  2022-09-28       Impact factor: 3.667

4.  Understanding Nonadherence to Tuberculosis Medications in India Using Urine Drug Metabolite Testing: A Cohort Study.

Authors:  Ramnath Subbaraman; Beena E Thomas; J Vignesh Kumar; Kannan Thiruvengadam; Amit Khandewale; S Kokila; Maya Lubeck-Schricker; M Ranjith Kumar; Gunjan Rahul Gaurkhede; Apurva Shashikant Walgude; J Hephzibah Mercy; Jagannath Dattatraya Kumbhar; Misha Eliasziw; Kenneth H Mayer; Jessica E Haberer
Journal:  Open Forum Infect Dis       Date:  2021-05-05       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.